Skip to main content
Caplight Logo









Geneial, Inc.

Geneial, Inc.

Private
Missouri City, TexasHealthcare & Life Scienceshttps://geneial.com/

Last Round

Grant

Nov 1, 2023

Total Funding Raised

$2.3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Geneial, Inc. is a healthcare technology company that provides a precision medicine data infrastructure and patient engagement platform for rare and genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Precision Medicine, Patient Engagement, Data Integration

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

rare disease registrypatient advocacyclinical trial recruitmentprecision medicinehealth data infrastructurepatient-led datalongitudinal datadata standardizationREDCap integrationFHIRhealth techreal-world evidenceRWEclinical research softwarepatient registry software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geneial, Inc. Comparables

Compare Geneial, Inc. with similar companies based on industry and business-model similarity.

Geneial, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulse Infoframe
86%
Across Healthcare
79%
Citizen Health
77%

Geneial, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2023
GrantSep 22, 2022
Pre SeedJun 1, 2021

Key People

Founding team and executive leadership

Adam Hansen

CEO & Founder

Founding Team

Geneial, Inc. Investors

Notable investors and investment history

Geneial, Inc. investors
InvestorRounds
National Library of MedicineGrant
NIH RADxGrant
Creative Destruction LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 44% MoM, reaching 2.8K.

  • Mar 3, 2026

    Monthly visitors increased 52% MoM.

Geneial, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Geneial, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Geneial, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMissouri City, Texas
Employee Range6
Year Founded2020
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?